LONGEVA.

GHRP-2: adverse events and evidence limits

Acute IV GHRP-2 tests in six healthy adults aged 22–27 showed prolactin, ACTH and cortisol increases. [1]

These are hormonal measurements; the read abstract does not establish clinical adverse-event frequencies. [1]

What the studies reported

EffectModel or participantsHow often or as describedSource
Prolactin increaseSix healthy adults aged 22–27, acute intravenous testsObserved; this is a hormonal measurement, not a clinical adverse-event frequency[1]
ACTH increaseThe same participantsObserved; a hormonal measurement — clinical adverse-event frequencies are not established[1]
Cortisol increaseThe same participantsObserved; a hormonal measurement — clinical adverse-event frequencies are not established[1]

References

  1. E Arvat et al. (1997). Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH https://doi.org/10.1016/S0196-9781(97)00016-8.